Sinclair Pharma (XPAR:SPH) Equity-to-Asset : 0.53 (As of Jun. 2018)

Sinclair Pharma Equity-to-Asset Chart

Sinclair Pharma Annual Data
	Trend	Jun07	Jun08	Jun09	Jun10	Jun11	Jun12	Jun13	Jun14	Jun15	Dec17
Equity-to-Asset		Get a 7-Day Free Trial					0.70	0.71	0.39	0.37	0.59

Sinclair Pharma Semi-Annual Data
	Jun08	Dec08	Jun09	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Jun17	Dec17	Jun18
Equity-to-Asset	Get a 7-Day Free Trial															0.47	0.60	0.56	0.59	0.53

Competitive Comparison of Sinclair Pharma's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Sinclair Pharma's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sinclair Pharma's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sinclair Pharma's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Sinclair Pharma's Equity-to-Asset falls into.

Sinclair Pharma Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Sinclair Pharma's Equity to Asset Ratio for the fiscal year that ended in Dec. 2017 is calculated as

Sinclair Pharma's Equity to Asset Ratio for the quarter that ended in Jun. 2018 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sinclair Pharma  (XPAR:SPH) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Sinclair Pharma Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Sinclair Pharma's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinclair Pharma (XPAR:SPH) Business Description